About MIVI Neuroscience
MIVI Neuroscience is a private company based in Eden Prairie, Minnesota. It has reported $67,432,153 raised in nine offerings on Form D since March 2017.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 15, 2024 | May 24, 2024 | $510,000of $9.2M target | 9 | $56,667 | Debt, Options, Convertible Notes & Warrants including the shares of capital stock issuable upon the conversion or exchange thereof.Rule 506(b) | Form D ↗ |
| Jul 14, 2023 | Aug 1, 2023 | $9,595,050of $10.0M target | 83 | $115K | Debt, Options, Convertible Notes & Warrants including the shares of capital stock issuable upon the conversion or exchange thereof.Rule 506(b) | Form D ↗ |
| Dec 18, 2020 | Dec 30, 2020 | $45,000,000fully sold | 48 | $937K | EquityRule 506(b) | Form D ↗ |
| Mar 10, 2020 | Mar 20, 2020 | $2,159,278of $2.5M target | 44 | $49,075 | Debt, Options, Senior Subordinated Convertible Promissory Notes; proportionate shares of Series A Preferred Stock & Warrants exercisable to purchase proportional shares of common stock for no additional considerationRule 506(b) | Form D ↗ |
| Jan 25, 2019 | Feb 7, 2019 | $3,175,863of $10.0M target | 17 | $186K | Equity, Series A Preferred StockRule 506(b) | Form D ↗ |
| Nov 28, 2018 | Dec 4, 2018 | $500,000of $1.0M target | 4 | $125K | Options, Senior Subordinated Convertible Promissory NotesRule 506(b) | Form D ↗ |
| Sep 1, 2017 | Sep 7, 2017 | $1,642,362fully sold | 27 | $60,828 | Equity, Conversion of Promissory Notes to EquityRule 506(b) | Form D ↗ |
| Aug 9, 2017 | Aug 18, 2017 | $4,000,000fully sold | 1 | $4.0M | Debt, Options, Promissory Note and WarrantRule 506(b) | Form D ↗ |
| Mar 17, 2017 | Mar 22, 2017 | $849,600fully sold | 14 | $60,686 | DebtRule 506(b) | Form D ↗ |
| Total, nine offerings | $67,432,153 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on MIVI Neuroscience's Form D filed May 24, 2024.
Earlier filings also listed Sean Cheng (director, last listed Dec 2020), Frederic Moll (director, last listed Dec 2020), Craig Yeshton (director, last listed Dec 2020), Maurice Ferre (director, last listed Mar 2020), Matthew Ogle (executive officer, last listed Mar 2020), James McCollum (ceo and director, last listed Mar 2020), Benjamin Constable (director, last listed Mar 2020) and John O'Meara (director, last listed Feb 2019).